Extending Outcomes for Pancreas Cancer Patients with Nominal Oligometastatic Disease (EXPAND): a Randomized Phase III Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The EXPAND trial (EXtending outcomes for PAncreas cancer patients with Nominal oligometastatic Disease) is a randomized phase III trial assessing the efficacy of MDT to improve PFS and OS for patients with oligometastatic pancreatic ductal adenocarcinoma (PDAC).
Epistemonikos ID: 12999b3686cabb85ac881d28b43f6604c2e36c75
First added on: Oct 01, 2024